| Enhancer ID: | E_01_0316 |
| Species: | human |
| Position : | chr19:17400341-17402341 |
| Biosample name: | |
| Experiment class : | High+Lowthroughput |
| Enhancer type: | Enhancer |
| Disease: | Mammary cancer |
| Pubmed ID: | 30655550 |
| Enhancer experiment: | PCR?Western blot?ChIP-seq |
| Enhancer experiment description: | CBX6 induced significant downregulation of bone marrow stromal cell antigen-2 (BST2), a potential therapeutic target, via interactions with its promoter region. Our collective findings support a tumor suppressor role of CBX6 in breast cancer. |
| Target gene : | BST2 |
| Strong evidence: | qRT-PCR,qPCR,ChIP,3C |
| Less strong evidence: | RNA-Seq |
| Target gene experiment description: | CBX6 induced significant downregulation of bone marrow stromal cell antigen-2 (BST2), a potential therapeutic target, via interactions with its promoter region. Our collective findings support a tumor suppressor role of CBX6 in breast cancer. |
| TF name : | -- |
| TF experiment: | PCR?Western blot?ChIP-seq |
| TF experiment description: | CBX6 induced significant downregulation of bone marrow stromal cell antigen-2 (BST2), a potential therapeutic target, via interactions with its promoter region. Our collective findings support a tumor suppressor role of CBX6 in breast cancer. |
| Enhancer function : | CBX6 induced significant downregulation of bone marrow stromal cell antigen-2 (BST2), a potential therapeutic target, via interactions with its promoter region. Our collective findings support a tumor suppressor role of CBX6 in breast cancer. |
| Enhancer function experiment: | Immunohistochemical staining |
| Enhancer function experiment description: |
CBX6 induced significant downregulation of bone marrow stromal cell antigen-2 (BST2), a potential therapeutic target, via interactions with its promoter region. Our collective findings support a tumor suppressor role of CBX6 in breast cancer. |
| SNP ID: | -- |
| GeneName | Pathway Name | Source | Gene Number |
|---|